Skip to main content
Cart 0
  1. Courses
  2. Waiver of Patent Protection...

Waiver of Patent Protection for COVID Vaccines

Explore the intellectual property landscape for vaccines against emerging pathogens, such as the one causing COVID-19.

Then discuss the hurdles to the transfer of vaccine technology, particularly during pandemics and other large-scale epidemics, and address mechanisms that have recently been used or proposed to facilitate the licensure of vaccine technology, including patent pools, pledges and the proposed IP waiver.

SPEAKERS

  • Ana Santos Rutschman, Saint Louis University, St. Louis, MO

PRODUCED
Session from 2022 Intellectual Property Law Section Program, March 31, 2022

APPROVED CREDIT
North Carolina: 1.25 MCLE Hours

PROGRAM PRICING
See pricing below.

Access to the program and content expires ninety (90) days from the date of purchase.